Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-23-001526
Filing Date
2023-04-25
Accepted
2023-04-25 16:40:08
Documents
3
Period of Report
2023-04-25

Document Format Files

Seq Description Document Type Size
1 6-K zk2329585.htm 6-K 15880
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 10815
3 image1.jpg GRAPHIC 21136
  Complete submission text file 0001178913-23-001526.txt   56957
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-22320 | Film No.: 23845444
SIC: 2835 In Vitro & In Vivo Diagnostic Substances